Richter invests in biotech
The listed pharmaceutical company Richter Gedeon Nyrt and the Hamburg-based Helm AG have jointly bought the Strathmann Biotec GmbH for €22.9 million ($31.6 million), Richter announced on the Budapest Stock Exchange (BÉT) website on Monday.
Richter has 70%, while Helm 30% stake in the new joint venture company. Strathmann Biotec GmbH, a subsidiary of the German Strathmann Dr. Detlef Strathmann Verwaltungs GmbH, includes a state-of-the-art biotechnological plant specialized in the bacteriological branch of biotechnology as well as capacities for R&D and laboratories. The company employs 81 workers. The contract will be effective as soon as the German competition office approves of it. (Gazdasági Rádió, Magyar Hirlap)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.